BiotechTube
Home/Anebulo Pharmaceuticals/Dr. Kenneth Cundy, Ph.D.
DK

Dr. Kenneth Cundy, Ph.D.

Chief Scientific Officer

Anebulo Pharmaceuticals

Therapeutic Areas

Acute Cannabinoid IntoxicationSubstance Use Disorders

Anebulo Pharmaceuticals Pipeline

DrugIndicationPhase
ANEB-001Acute Cannabinoid Intoxication / Unintentional Cannabis PoisoningPhase 2

Leadership Team at Anebulo Pharmaceuticals

RC
Richie Cunningham
Chief Executive Officer
DG
Daniel George
Acting Chief Financial Officer
View full Anebulo Pharmaceuticals profile